LPL Financial’s Dare Bioscience DARE Stock Holding History

LPL Financial’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.4K	Buy	14,889 +250	+2%	+$559	﹤0.01%	6082
2026 Q1	$26.6K	Hold	14,639	–	–	﹤0.01%	5849
2025 Q4	$28.3K	Buy	+14,639	New	+$29.2K	﹤0.01%	5773

Other funds holding DARE

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

LPL Financial's DARE Position: Q2 2026 in Review

LPL Financial increased its Dare Bioscience (DARE) stake by 1.7% in Q2 2026, buying an estimated $559 and bringing the position to 14,889 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6082.

LPL Financial first reported a position in DARE in Q4 2025 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

LPL Financial held 14,889 shares of Dare Bioscience worth $31.4K as of Q2 2026.
LPL Financial bought 250 Dare Bioscience shares in Q2 2026, an estimated $559.
Dare Bioscience made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6082 holding.
LPL Financial first reported a position in Dare Bioscience in Q4 2025 and has held it in 3 quarters since.
27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.